cbdMD Announces Hiring of Chief Marketing Officer

Matt Coapman Brings 15 years of Experience in Digital Development and Strategy

CHARLOTTE, N.C.--(BUSINESS WIRE)-- cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most highly trusted and best recognized CBD companies, announced the hiring of Matt Coapman as the Chief Marketing Officer.

“Matt brings over 15 years of experience in the world of digital marketing and ecommerce strategy execution to the company. Since 2016, Matt has been a Partner at consumer goods think tank Dingoz Consulting, where he helped clients with their product launches and ecommerce development. Prior to that role, from 2010 to 2016, he was the Vice President of Marketing for blu eCigs^®, one of the most recognized brands in the e-cig industry. In 2013, blu eCigs^® was acquired by Fontem Ventures, a wholly owned subsidiary of Imperial Tobacco. During Matt’s tenure with Fontem, blu eCigs^® launched new products and flavors and embarked on a national TV, print, retail, online, and social media marketing campaign, which resulted in blu eCigs^® becoming the most recognized e-cig brand in the world,” said Scott Coffman, co-CEO of cbdMD, Inc. and the founder of blu eCigs^®.

In his role as Chief Marketing Officer, Mr. Coapman will be responsible for developing and executing strategies that help drive sustainable growth, create greater customer engagement and conversion, amplify brand messaging and deliver both top and bottom-line results.

“It’s a very fortuitous time to enter the CBD industry and to join the team at cbdMD. I’ve built a career around helping brands bring their product and voice to life. I’m looking forward to getting started and helping the company expand on what has been built with the cbdMD, Paw CBD and cbdMD Botanicals brands,” said Matt Coapman, Chief Marketing Officer at cbdMD, Inc.

About cbdMD, Inc.

cbdMD, Inc. is one of the leading, most highly trusted and most recognized cannabidiol (CBD) brands, with a comprehensive line of U.S.-produced, THC-free¹ CBD products. The cbdMD brand currently includes over 130 SKUs of high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleep aids, CBD drink mixes and full spectrum CBD options. Our Paw CBD brand of pet products includes over 45 SKUs of veterinarian-formulated products, including tinctures, chews, topicals products in varying strengths, and our CBD Botanicals brand of beauty and skincare products features 15 SKUs, including facial oil and serum, toners, moisturizers, facial masks, exfoliants and body care. The company also offers a line of full spectrum products (approximately 10 SKUs) under its cbdMD brand. To learn more about cbdMD and their comprehensive line of U.S.-grown, THC-free¹ CBD oil products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the 6,000 retail outlets that carry cbdMD products.

¹ THC-free is defined as below the level of detection using validated scientific analytical methods.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005433/en/

PR:

cbdMD, Inc.

Robert Pettway

Director of Public Relations

rpettway@cbdmd.com

(423) 503-5225

Investors:

cbdMD, Inc.

John Weston

Director of Investor Relations

john.weston@cbdmd.com

(704) 249-9515

Source: cbdMD, Inc.